Apple
2022 outlook for small/microcaps
What the new #omicron lockdowns mean for investors.
Equals
AstraZeneca
Boohoo
Possible options to convert of Amryt Pharma shares into Nasdaq ADS’s (5:1 ratio)
Oncimmune
Getech, pivoting towards ‘Green Hydrogen’
Two ‘potential’ fallen angles for 2022